Literature DB >> 22641683

Antiretroviral medication for preventing HIV infection in nonoccupational settings.

Isaac I Bogoch1, Eileen P Scully, Kimon C Zachary.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22641683      PMCID: PMC3394821          DOI: 10.1503/cmaj.120267

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  19 in total

Review 1.  Acute human immunodeficiency virus type 1 infection.

Authors:  J O Kahn; B D Walker
Journal:  N Engl J Med       Date:  1998-07-02       Impact factor: 91.245

2.  Effectiveness of postinoculation (R)-9-(2-phosphonylmethoxypropyl) adenine treatment for prevention of persistent simian immunodeficiency virus SIVmne infection depends critically on timing of initiation and duration of treatment.

Authors:  C C Tsai; P Emau; K E Follis; T W Beck; R E Benveniste; N Bischofberger; J D Lifson; W R Morton
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

3.  Raltegravir, tenofovir DF, and emtricitabine for postexposure prophylaxis to prevent the sexual transmission of HIV: safety, tolerability, and adherence.

Authors:  Kenneth H Mayer; Matthew J Mimiaga; Marcy Gelman; Chris Grasso
Journal:  J Acquir Immune Defic Syndr       Date:  2012-04-01       Impact factor: 3.731

4.  HIV incidence among New Haven needle exchange participants: updated estimates from syringe tracking and testing data.

Authors:  E H Kaplan; R Heimer
Journal:  J Acquir Immune Defic Syndr Hum Retrovirol       Date:  1995-10-01

5.  Antiretroviral postexposure prophylaxis after sexual, injection-drug use, or other nonoccupational exposure to HIV in the United States: recommendations from the U.S. Department of Health and Human Services.

Authors:  Dawn K Smith; Lisa A Grohskopf; Roberta J Black; Judith D Auerbach; Fulvia Veronese; Kimberly A Struble; Laura Cheever; Michael Johnson; Lynn A Paxton; Ida M Onorato; Alan E Greenberg
Journal:  MMWR Recomm Rep       Date:  2005-01-21

6.  Reducing the risk of sexual HIV transmission: quantifying the per-act risk for HIV on the basis of choice of partner, sex act, and condom use.

Authors:  Beens Varghese; Julie E Maher; Thomas A Peterman; Bernard M Branson; Richard W Steketee
Journal:  Sex Transm Dis       Date:  2002-01       Impact factor: 2.830

7.  Seroconversion following nonoccupational postexposure prophylaxis against HIV.

Authors:  Michelle E Roland; Torsten B Neilands; Melissa R Krone; Mitchell H Katz; Karena Franses; Robert M Grant; Michael P Busch; Frederick M Hecht; Barbara L Shacklett; James O Kahn; Joshua D Bamberger; Thomas J Coates; Margaret A Chesney; Jeffrey N Martin
Journal:  Clin Infect Dis       Date:  2005-10-13       Impact factor: 9.079

8.  A case-control study of HIV seroconversion in health care workers after percutaneous exposure. Centers for Disease Control and Prevention Needlestick Surveillance Group.

Authors:  D M Cardo; D H Culver; C A Ciesielski; P U Srivastava; R Marcus; D Abiteboul; J Heptonstall; G Ippolito; F Lot; P S McKibben; D M Bell
Journal:  N Engl J Med       Date:  1997-11-20       Impact factor: 91.245

9.  Comparison of female to male and male to female transmission of HIV in 563 stable couples. European Study Group on Heterosexual Transmission of HIV.

Authors: 
Journal:  BMJ       Date:  1992-03-28

10.  Heterosexual transmission of human immunodeficiency virus: variability of infectivity throughout the course of infection. European Study Group on Heterosexual Transmission of HIV.

Authors:  B Leynaert; A M Downs; I de Vincenzi
Journal:  Am J Epidemiol       Date:  1998-07-01       Impact factor: 4.897

View more
  2 in total

1. 

Authors:  Amila Heendeniya; Ethan Tumarkin; Isaac I Bogoch
Journal:  Can Fam Physician       Date:  2019-04       Impact factor: 3.275

2.  HIV preexposure prophylaxis in Canadian primary care and community settings.

Authors:  Amila Heendeniya; Ethan Tumarkin; Isaac I Bogoch
Journal:  Can Fam Physician       Date:  2019-04       Impact factor: 3.275

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.